News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions Podcast
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPartnersPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksState of the ScienceWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement

USP

Advertisement

Articles by USP

Strengthening Your Compendial Strategy

Strengthening Your Compendial Strategy

ByUSP
April 22nd 2025

Webinar Date/Time: Tue, May 13, 2025 11:00 AM EDT

USP Biologics

ByUSP
June 2nd 2022

USP offers a growing portfolio of well characterized monoclonal antibody (mAb) reference standards and associated characterization data.

COVID-19's Impact: Help Ensure Quality and Manage Risk

ByUSP
October 21st 2020

COVID-19’s Impact: Help Ensure Quality and Manage Risk

ByUSP
October 19th 2020

Dissolution and the USP Performance Verification Test

ByUSP
January 23rd 2019

Risk Assessments and Sourcing Strategies for Excipients and APIs

ByUSP
January 2nd 2018
Advertisement

Latest Updated Articles

  • USP Biologics
    USP Biologics

    Published: June 2nd 2022 | Updated:

  • COVID-19’s Impact: Help Ensure Quality and Manage Risk
    COVID-19’s Impact: Help Ensure Quality and Manage Risk

    Published: October 19th 2020 | Updated:

  • Risk Assessments and Sourcing Strategies for Excipients and APIs
    Risk Assessments and Sourcing Strategies for Excipients and APIs

    Published: January 2nd 2018 | Updated:

  • Dissolution and the USP Performance Verification Test
    Dissolution and the USP Performance Verification Test

    Published: January 23rd 2019 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

Batch Certification for New Manufacturing Technologies: The Qualified Person Role in a Digital Environment

2

Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First

3

BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation

4

FDA Deploys Agentic AI Capabilities for Agency Staff

5

How a “Plan, Prevent, Prove” Approach Helps Avoid Facility and Equipment Problems

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us